SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptor
Journal of Virology · 19.11.2024 · 98 (11)
DOI: 10.1128/jvi.00754-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, erschienen am 19.11.2024. Verfasst von Cuiling Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China. Hauptthemen laut MEDLINE: Autophagosomes, Virus Replication, SARS-CoV-2, Sigma-1 Receptor. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Province Science and technology development plan youth growth science and technology, Natural Science Foundation of Jilin Province (Jilin Natural Science Foundation), MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Autophagy is a cellular self-defense mechanism by which cells can kill invading pathogenic microorganisms and increase the presentation of components of pathogens as antigens. Contrarily, pathogens can utilize autophagy to enhance their own replication. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) NSP6 can interact with ATPase proton pump component to inhibit lysosomal acidification, which was implicated in the autophagy process. However, research on how SARS-CoV-2 NSP6 affected autophagy, and its impact on virus replication is still lacking. Coronavirus NSP6 has been reported to promote coronavirus replication by limiting autophagosome expansion. However, this finding has not been confirmed in coronavirus disease 2019 (COVID-19). We investigated the effect of NSP6 protein on autophagosomes in different mutant strains of SARS-CoV-2 and revealed that the size of autophagosomes was reduced by NSP6 of the wild-type and Delta variant of SARS-CoV-2. In addition, we found that SARS-CoV-2 NSP6 localized to the lysosome and had an inhibitory effect on the binding of autophagosomes to the lysosome, which blocked the autophagy flux; this may be related to endoplasmic reticulum (ER)-related pathways. We also found that sigma-1 receptor (SIGMAR1) knock out (KO) reversed NSP6-induced autophagosome abnormality and resisted SARS-CoV-2 infection, which responds to the fact that SIGMAR1 is likely to be used as a potential target for the treatment of SARS-CoV-2 infection. In summary, we have provided a preliminary explanation of the effects on autophagy of the SARS-CoV-2 NSP6 protein from the pre-autophagic and late stages, and also found that SIGMAR1 is likely to be used as a potential target for SARS-CoV-2 therapy to develop relevant drugs. IMPORTANCE We have provided a preliminary explanation of the effects on autophagy of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non-structure protein 6 from the pre-autophagic and late stages, and also found that sigma-1 receptor is likely to be used as a potential target for SARS-CoV-2 therapy to develop relevant drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
- Jiangxi Provincial Key Laboratory of Systems Biomedicine, Jiujiang University, Jiujiang, China.
- Department of Neurosurgery, First Hospital of Jilin University, Changchun, China.
- Department of Chemistry, Northeastern University, Shenyang, China.
- Key Laboratory of Jilin Province for Traditional Chinese Medicine Prevention and Treatment of Infectious Diseases, College of Integrative Medicine, Changchun University of Chinese Medicine, Changchun, China.
ORCID-Profile: Cuiling Zhang, Yan Liu, Xiao Li, Chao Shang, Yiquan Li
Förderung
- Jilin Province Science and technology development plan youth growth science and technology
- Natural Science Foundation of Jilin Province (Jilin Natural Science Foundation)
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Zhang, C., Jiang, Q., Liu, Z., Li, N., Hao, Z., Song, G., Li, D., Chen, M., Lin, L., Liu, Y., Li, X., Shang, C., & Li, Y. (2024). SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptor. Journal of Virology, 98(11). https://doi.org/10.1128/jvi.00754-24
Vancouver
Zhang C, Jiang Q, Liu Z, Li N, Hao Z, Song G, et al. SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptor. Journal of Virology. 2024;98(11). doi:10.1128/jvi.00754-24
BibTeX
@article{Zhang2024,
author = {Zhang, Cuiling and Jiang, Qiwei and Liu, Zirui and Li, Nan and Hao, Zhuo and Song, Gaojie and Li, Dapeng and Chen, Minghua and Lin, Lisen and Liu, Yan and Li, Xiao and Shang, Chao and Li, Yiquan},
title = {SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptor},
journal = {Journal of Virology},
year = {2024},
volume = {98},
number = {11},
doi = {10.1128/jvi.00754-24}
}
EUVIMED